Review of Data from the ASCO 2020 Virtual Meeting
EP. 1: Metastatic HR+ Breast Cancer Updates
BySara A. Hurvitz, MD, David Geffen School of Medicine,Aditya Bardia, MD, MPH, FASCO,Claudine Isaacs, MD, Lombardi Comprehensive Cancer Center,Sara Tolaney, MD, MPH, Dana-Farber Harvard Cancer Center 
EP. 2: ASCO 2020 Data Updates: Metastatic HER2+ Breast Cancer
BySara A. Hurvitz, MD, David Geffen School of Medicine,Aditya Bardia, MD, MPH, FASCO,Claudine Isaacs, MD, Lombardi Comprehensive Cancer Center,Sara Tolaney, MD, MPH, Dana-Farber Harvard Cancer Center 
EP. 3: Metastatic Triple-Negative Breast Cancer Ongoing Trials
BySara A. Hurvitz, MD, David Geffen School of Medicine,Aditya Bardia, MD, MPH, FASCO,Claudine Isaacs, MD, Lombardi Comprehensive Cancer Center,Sara Tolaney, MD, MPH, Dana-Farber Harvard Cancer Center 
EP. 4: Perioperative Therapy: ASCO 2020 Data Updates
BySara A. Hurvitz, MD, David Geffen School of Medicine,Aditya Bardia, MD, MPH, FASCO,Claudine Isaacs, MD, Lombardi Comprehensive Cancer Center,Sara Tolaney, MD, MPH, Dana-Farber Harvard Cancer Center 